| PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells P Neviani, JG Harb, JJ Oaks, R Santhanam, CJ Walker, JJ Ellis, ... The Journal of clinical investigation 123 (10), 4144-4157, 2013 | 265 | 2013 |
| Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis AM Nicaise, LJ Wagstaff, CM Willis, C Paisie, H Chandok, P Robson, ... Proceedings of the National Academy of Sciences 116 (18), 9030-9039, 2019 | 189 | 2019 |
| Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options P Gasparini, M Fassan, L Cascione, G Guler, S Balci, C Irkkan, C Paisie, ... PLoS One 9 (2), e88525, 2014 | 112 | 2014 |
| CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence Y Zhao, Z Pan, S Namburi, A Pattison, A Posner, S Balachander, ... EBioMedicine 61, 2020 | 87 | 2020 |
| Morphologically Normal-Appearing Mammary Epithelial Cells Obtained from High-Risk Women Exhibit Methylation Silencing of INK4a/ARF GR Bean, AD Bryson, PG Pilie, V Goldenberg, JC Baker Jr, C Ibarra, ... Clinical cancer research 13 (22), 6834-6841, 2007 | 62 | 2007 |
| CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis SN Vasilatos, G Broadwater, WT Barry, JC Baker Jr, S Lem, EC Dietze, ... Cancer Epidemiology Biomarkers & Prevention 18 (3), 901-914, 2009 | 59 | 2009 |
| A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation Y Wu, X Feng, Y Jin, Z Wu, W Hankey, C Paisie, L Li, F Liu, SH Barsky, ... Cancer Prevention Research 3 (7), 818-828, 2010 | 37 | 2010 |
| Replicative stress and the FHIT gene: roles in tumor suppression, genome stability and prevention of carcinogenesis JR Karras, CA Paisie, K Huebner Cancers 6 (2), 1208-1219, 2014 | 36 | 2014 |
| Hypermethylation of the Breast Cancer–Associated Gene 1 Promoter Does Not Predict Cytologic Atypia or Correlate with Surrogate End Points of Breast Cancer Risk GR Bean, C Ibarra Drendall, VK Goldenberg, JC Baker Jr, MM Troch, ... Cancer Epidemiology Biomarkers & Prevention 16 (1), 50-56, 2007 | 36 | 2007 |
| Fhit deficiency-induced global genome instability promotes mutation and clonal expansion S Miuma, JC Saldivar, JR Karras, CE Waters, CA Paisie, Y Wang, V Jin, ... PLoS One 8 (11), e80730, 2013 | 34 | 2013 |
| The ubiquitous ‘cancer mutational signature’5 occurs specifically in cancers with deleted FHIT alleles S Volinia, T Druck, CA Paisie, MS Schrock, K Huebner Oncotarget 8 (60), 102199, 2017 | 20 | 2017 |
| Exome‐wide single‐base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse CA Paisie, MS Schrock, JR Karras, J Zhang, S Miuma, IM Ouda, ... Cancer science 107 (4), 528-535, 2016 | 19 | 2016 |
| BCR-ABL1 kinase activity but not its expression is dispensable for Ph+ quiescent stem cell survival which depends on the PP2A-controlled Jak2 activation and is sensitive to … P Neviani, JG Harb, JJ Oaks, C Walker, R Santhanam, C Paisie, A Eiring, ... Blood 116 (21), 515, 2010 | 13 | 2010 |
| A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer XY Woo, A Srivastava, PC Mack, JH Graber, BJ Sanderson, MW Lloyd, ... Cancer research 82 (22), 4126-4138, 2022 | 12 | 2022 |
| ESR1 Promoter Hypermethylation Does Not Predict Atypia in RPFNA nor Persistent Atypia after 12 Months Tamoxifen Chemoprevention JC Baker Jr, JH Ostrander, S Lem, G Broadwater, GR Bean, NC D'Amato, ... Cancer Epidemiology Biomarkers & Prevention 17 (8), 1884-1890, 2008 | 10 | 2008 |
| Pan-cancer machine learning predictors of primary site of origin and molecular subtype WF Flynn, S Namburi, CA Paisie, HV Reddi, S Li, RKM Karuturi, J George BioRxiv, 333914, 2018 | 8 | 2018 |
| RNA-seq analysis reveals differences in transcript abundance between cultured and sand fly-derived Leishmania infantum promastigotes PJ Alcolea, A Alonso, L Baugh, C Paisie, G Ramasamy, A Sekar, A Sur, ... Parasitology international 67 (4), 476-480, 2018 | 5 | 2018 |
| Protein coding variation in the J: ARC and J: DO outbred laboratory mouse stocks provides a molecular basis for distinct research applications BK Cornes, C Paisie, E Swanzey, PD Fields, A Schile, K Brackett, ... G3: Genes, Genomes, Genetics 13 (4), jkad015, 2023 | 2 | 2023 |
| Nuclear export (karyopherin) inhibitors: A novel therapeutic strategy for treating Philadelphia-positive (Ph+) acute leukemias C Walker, JJ Oaks, R Santhanam, P Neviani, JG Harb, C Paisie, ... Cancer Research 72 (8_Supplement), 3839-3839, 2012 | 2 | 2012 |
| BCR-ABL1 kinase activity but not its expression is dispensable for Ph plus quiescent stem cell survival which depends on the PP2A-controlled Jak2 activation and is sensitive to … P Neviani, JG Harb, JJ Oaks, C Walker, R Santhanam, C Paisie, A Eiring, ... Blood 116 (21), 227-228, 2010 | 2 | 2010 |
